Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide

被引:1
|
作者
Watanabe, H
Takehana, K
Date, M
Shinozaki, T
Raz, A
机构
[1] WAYNE STATE UNIV, SCH MED, BARBARA ANN KARMANOS CANC INST, DETROIT, MI 48201 USA
[2] GUNMA UNIV, SCH MED, DEPT ORTHOPED SURG, MAEBASHI, GUMMA 371, JAPAN
[3] AJINOMOTO CO INC, CENT RES LABS, KAWASAKI KU, KAWASAKI, KANAGAWA 210, JAPAN
[4] WAYNE STATE UNIV, SCH MED, DEPT PATHOL, DETROIT, MI 48201 USA
[5] WAYNE STATE UNIV, SCH MED, DEPT RADIAT ONCOL, DETROIT, MI 48201 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To date, the structure of the autocrine motility factor (AMF), a tumor-secreted cytokine which stimulates cell migration in vitro and metastasis in vivo, is unknown. Here, AMF secreted by Gc-4 PF murine fibrosarcoma into a protein-free conditioned media was isolated, purified, and microsequenced, The results demonstrate that AMF is the previously cloned cytokine and enzyme designated as neuroleukin, and phosphohexose isomerase (PHI), which has been independently implicated in cell motility, and to be a cancer progression marker. PHI catalyzes isomerization of glucose 6-phosphate to fructose 6-phosphate and is specific for both sugars. Murine AMF exhibits the enzymatic properties of PHI and rabbit heart PHI-stimulated mouse fibrosarcoma cells' motility similar to those of the endogenous AMF. Specific PHI inhibitors (carbohydrate phosphates) inhibited enzymatic activity and AMF-induced cell motility.
引用
收藏
页码:2960 / 2963
页数:4
相关论文
共 50 条
  • [31] Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release
    Fu, M.
    Li, L.
    Albrecht, T.
    Johnson, J. D.
    Kojic, L. D.
    Nabi, I. R.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (06): : 1057 - 1070
  • [32] Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer
    Funasaka, Tatsuyoshi
    Hogan, Victor
    Raz, Avraham
    CANCER RESEARCH, 2009, 69 (13) : 5349 - 5356
  • [33] PH-specific sequestration of phosphoglucose isomerase/autocrine motility factor by fibronectin and heparan sulphate
    Lagana, A
    Goetz, JG
    Y, N
    Altschuler, Y
    Nabi, IR
    JOURNAL OF CELL SCIENCE, 2005, 118 (18) : 4175 - 4185
  • [34] Autocrine motility factor receptor expression associates with tumor progression in thymoma
    Ohta, Y
    Minato, H
    Tanaka, Y
    Go, T
    Oda, M
    Watanabe, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (02) : 259 - 264
  • [35] Heregulin regulation of autocrine motility factor expression in human tumor cells
    Talukder, AH
    Adam, L
    Raz, A
    Kumar, R
    CANCER RESEARCH, 2000, 60 (02) : 474 - 480
  • [36] Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines
    Takanami, I
    Takeuchi, K
    Watanabe, H
    Yanagawa, T
    Takagishi, K
    ONCOLOGY REPORTS, 2002, 9 (01) : 125 - 128
  • [37] PURIFICATION OF HUMAN TUMOR-CELL AUTOCRINE MOTILITY FACTOR AND MOLECULAR-CLONING OF ITS RECEPTOR
    WATANABE, H
    CARMI, P
    HOGAN, V
    RAZ, T
    SILLETTI, S
    NABI, IR
    RAZ, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (20) : 13442 - 13448
  • [38] Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3
    Tian, Kang
    Zhong, Weiliang
    Zheng, Xifu
    Zhang, Jinrui
    Liu, Pixu
    Zhang, Weiguo
    Liu, Han
    SCIENTIFIC REPORTS, 2015, 5
  • [39] EFFECTS OF PROTEIN-KINASE INHIBITORS ON THE CELL MOTILITY STIMULATED BY AUTOCRINE MOTILITY FACTOR
    KANBE, K
    CHIGIRA, M
    WATANABE, H
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1222 (03): : 395 - 399
  • [40] Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3
    Kang Tian
    Weiliang Zhong
    Xifu Zheng
    Jinrui Zhang
    Pixu Liu
    Weiguo Zhang
    Han Liu
    Scientific Reports, 5